Hanger Orthopedic Group Increases Q4 2009 Sales and EPS Guidance
13 January 2010 - 1:17AM
PR Newswire (US)
Announces plans to relocate corporate headquarters to Austin, Texas
BETHESDA, Md., Jan. 12 /PRNewswire-FirstCall/ -- Hanger Orthopedic
Group, Inc. (NYSE:HGR) announced today that it expects to report
record fourth quarter sales of approximately $205 million. Given
the higher than expected sales volume and continued emphasis on
cost control, the Company expects to report earnings per share in
the range of $0.35 to $0.38 for the quarter. The revised earnings
per share estimate represents between 35% and 46% growth for the
quarter. Based on the new fourth quarter estimates, the Company
expects to report approximately $760 million in sales and earnings
per share in the range of $1.10 to $1.13 for the full year. "Our
employees did an outstanding job generating another record year of
sales and profits," Hanger Orthopedic Group President and CEO Tom
Kirk said. "I am very proud of their efforts and accomplishments
throughout 2009." The Company also announced the decision to
relocate its corporate headquarters to Austin, Texas from Bethesda,
Maryland. Hanger's new Austin headquarters will provide ample space
for future growth, improved operational efficiency, and an enhanced
quality of life for corporate employees. Austin's central location
in the United States will also facilitate improved communication
with Hanger's national footprint of more than 700 patient care
centers and supporting operational locations. Before deciding on
Austin, Hanger completed an analysis of numerous cities nationwide,
including the greater Washington, DC metro area. The relocation is
expected to be completed in the third quarter of 2010. "As the
market leader of the orthotic and prosthetic profession in the
United States, we promote creativity and innovation in our business
operations. Our new location embodies this spirit and will serve as
an ideal environment for us to continue our growth and disciplined
diversification strategy," Kirk said. "Additionally, we are
impressed with the professionalism and the support afforded to us
by the State of Texas and the City of Austin in facilitating our
decision-making process. Their outstanding assistance packages were
a key element of this support. We would also like to recognize the
helpful role played by the Austin Chamber of Commerce." In
consideration of its 130+ Bethesda-based corporate employees,
Hanger is offering relocation opportunities for all eligible staff
members who have an interest in moving to Austin, as well as
comprehensive separation packages including severance agreements
and benefits continuation for employees who choose not to relocate.
The relocation is expected to provide an excellent return on
investment without having any negative material impact on
operations. Additional information regarding the relocation, as
well as details of the fourth quarter performance and guidance for
2010, will be discussed on Hanger's fourth quarter earnings release
conference call at 9:00am EST on February 11, 2010. Call-in
information will be available soon in the newsroom of
http://www.hanger.com/. About Hanger Orthopedic Group, Inc.: Hanger
Orthopedic Group, Inc., headquartered in Bethesda, Maryland, is the
world's premier provider of orthotic and prosthetic patient care
services. Hanger is the market leader in the United States, owning
and operating 669 patient care centers in 45 states and the
District of Columbia, with over 3,700 employees including 1,095
practitioners (as of September 30, 2009). Hanger is organized into
four units. The two key operating units are patient care, which
consists of nationwide orthotic and prosthetic practice centers,
and distribution, which consists of distribution centers managing
the supply chain of orthotic and prosthetic componentry to Hanger
and third party patient care centers. The third is Linkia, which is
the first and only provider network management company for the
orthotics and prosthetics industry. The fourth unit, Innovative
Neurotronics, introduces emerging neuromuscular technologies
developed through independent research in a collaborative effort
with industry suppliers worldwide. For more information on
Innovative Neurotronics, Inc. or the WalkAide®, visit
http://www.ininc.us/. For more information on Hanger, visit
http://www.hanger.com/. This document may contain forward-looking
statements relating to the Company's revenues, contracts and
operations. The United States Private Securities Litigation Reform
Act of 1995 provides a "safe harbor" for certain forward-looking
statements. Statements relating to future revenues, contracts and
operations in this document reflect the current views of
management. However, various risks, uncertainties and contingencies
could cause actual results or performance to differ materially from
those expressed in, or implied by, these statements, including the
Company's ability to enter into and derive benefits from managed
care contracts, the demand for the Company's orthotic and
prosthetic services and products and the other factors identified
in the Company's periodic reports on Form 10-K and Form 10-Q filed
with the Securities and Exchange Commission under the Securities
Exchange Act of 1934. The Company disclaims any intent or
obligation to update publicly these forward-looking statements,
whether as a result of new information, future events or otherwise.
Investor Relations: Tom Hofmeister, 301-986-0701, Press Contact:
Jennifer Bittner, 904-249-4210, DATASOURCE: Hanger Orthopedic
Group, Inc. CONTACT: Investor Relations, Tom Hofmeister,
+1-301-986-0701, ; Press Contact, Jennifer Bittner,
+1-904-249-4210, , both of Hanger Orthopedic Group, Inc. Web Site:
http://www.hanger.com/
Copyright